Potential Biomarkers to Distinguish Type 1 Myocardial Infarction in Troponin-Elevated Diseases
Classifying myocardial infarction by subtype is crucial for appropriate patient management. Although troponin is currently the most commonly used biomarker, it is not a specific marker for myocardial infarction and cannot distinguish subtypes. Furthermore, previous studies have confirmed that protei...
Main Authors: | Kang, H.-G (Author), Kwon, S. (Author), Lee, J. (Author), Mun, S. (Author), Park, S.-H (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI
2023
|
Subjects: | |
Online Access: | View Fulltext in Publisher View in Scopus |
Similar Items
-
To compare four methods of CKMB measurement and the qualitative Troponin-T assay as diagnostic discriminants of acute myocardial infarction.
Published: (1996) -
Clinical indications for requesting high-sensitivity troponin I in the emergency department
by: Abdulhalim Jamal Kinsara, et al.
Published: (2020-01-01) -
Troponin I level in risk stratification of non-ST-elevation myocardial infarction in smokers
by: Iram Shahriar, Shahina Sobhan and Ziarrat Islam
Published: (2010-12-01) -
Troponin I level in risk stratification of non-ST-elevation myocardial infarction in smokers
by: Iram Shahriar, et al.
Published: (2011-01-01) -
Relationship Between Delta Troponin I Levels
And In-Hospital Cardiovascular Endpoints In Acute
ST Elevation Myocardial Infarction
by: Aydin Ercan, et al.
Published: (2019-10-01)